Zanubrutinib in Primary Cold Agglutinin Disease
Clinical trial NCT06067048 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06067048
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-26
- Primary completion
- 2026-02-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.